Biotech venture capital is supposed to be the highest-risk/highest-reward type of investment there is. But many biotech VCs are actually pretty conservative, hesitant to wager on edgy science that might take a decade to pay off.
{iframe}http://www.forbes.com/sites/luketimmerman/2016/10/31/third-rock-ventures-one-of-biotechs-daring-investors-raises-616m-for-more-startups/#214e0fdaf56d{/iframe}